de Miclén a. s.

As of the latest reporting, de Miclén a. s. does not have specific carbon emissions data available, indicating a lack of disclosed emissions figures. However, the company is a current subsidiary of GSK plc, which influences its climate commitments and initiatives.

De Miclén a. s. inherits its climate strategies and targets from GSK plc, which has established various initiatives aimed at reducing carbon emissions. These initiatives include commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded down to de Miclén a. s. from GSK plc.

While specific reduction targets for de Miclén a. s. are not detailed, the overarching goals set by GSK plc reflect a commitment to sustainability and significant reductions in carbon emissions across its operations. The absence of direct emissions data suggests that de Miclén a. s. may still be in the process of developing its own reporting framework or aligning with GSK plc's broader climate strategies.

In summary, while de Miclén a. s. currently lacks specific emissions data, it is aligned with the climate commitments of its parent company, GSK plc, which actively pursues ambitious sustainability goals.